MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

MDT

100.26

+3%↑

A

147.57

+3.37%↑

VEEV

238.01

+7.61%↑

HQY

94.97

+1.71%↑

PHR.US

17.21

+0.53%↑

Search

Phibro Animal Health Corp

Gesloten

SectorGezondheidszorg

39.5 2.97

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

37.94

Max

39.75

Belangrijke statistieken

By Trading Economics

Inkomsten

9.3M

27M

Verkoop

-15M

364M

K/W

Sectorgemiddelde

22.308

88.032

EPS

0.73

Dividendrendement

1.29

Winstmarge

7.29

Werknemers

2,475

EBITDA

22M

63M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+23.79% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.29%

2.26%

Volgende Winsten

4 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-203M

1.6B

Vorige openingsprijs

36.53

Vorige sluitingsprijs

39.5

Nieuwssentiment

By Acuity

29%

71%

73 / 373 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Phibro Animal Health Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 jan 2026, 21:14 UTC

Belangrijke Marktbewegers

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6 jan 2026, 19:23 UTC

Acquisities, Fusies, Overnames

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6 jan 2026, 17:41 UTC

Belangrijke Marktbewegers

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6 jan 2026, 15:46 UTC

Acquisities, Fusies, Overnames

Advent International Leads InPost Takeover Offer, Sky News Says

6 jan 2026, 15:37 UTC

Belangrijke Marktbewegers

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6 jan 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline After Hitting Record High -- Market Talk

6 jan 2026, 23:35 UTC

Marktinformatie

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6 jan 2026, 23:19 UTC

Marktinformatie

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6 jan 2026, 22:53 UTC

Marktinformatie

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

6 jan 2026, 21:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

6 jan 2026, 21:12 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

6 jan 2026, 21:12 UTC

Marktinformatie

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6 jan 2026, 20:59 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Deal Could Be Announced Imminently, Sources Say -- WSJ

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6 jan 2026, 20:01 UTC

Marktinformatie

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6 jan 2026, 19:52 UTC

Marktinformatie

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6 jan 2026, 19:46 UTC

Acquisities, Fusies, Overnames

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6 jan 2026, 19:08 UTC

Acquisities, Fusies, Overnames

OneStream to Go Private Through $6.4B Hg Acquisition

6 jan 2026, 18:28 UTC

Acquisities, Fusies, Overnames

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6 jan 2026, 17:20 UTC

Marktinformatie
Winsten

Financial Services Roundup: Market Talk

6 jan 2026, 17:20 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

6 jan 2026, 15:57 UTC

Marktinformatie

Crude Futures Ease Back From Early Gains -- Market Talk

6 jan 2026, 15:34 UTC

Marktinformatie
Winsten

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6 jan 2026, 15:27 UTC

Marktinformatie

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Peer Vergelijking

Prijswijziging

Phibro Animal Health Corp Prognose

Koersdoel

By TipRanks

23.79% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 47.5 USD  23.79%

Hoogste 50 USD

Laagste 45 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Phibro Animal Health Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Technische score

By Trading Central

17 / N/ASteun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Weak Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

73 / 373 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Phibro Animal Health Corp

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
help-icon Live chat